Literature DB >> 18419345

Immune responses to mumps vaccine in adults who were vaccinated in childhood.

Rima Hanna-Wakim1, Linda L Yasukawa, Phillip Sung, Ann M Arvin, Hayley A Gans.   

Abstract

BACKGROUND: In a mumps outbreak in the United States, many infected individuals were adults who had received 2 doses of mumps vaccine. The persistence of cellular immunity to mumps vaccine has not been defined.
METHODS: This was an observational, nonrandomized cohort study evaluating cell-mediated and humoral immunity to mumps in 10 vaccinated and 10 naturally immune adults. Mumps-specific T cell activation and interferon (IFN)-gamma production were measured using lymphoproliferative and flow cytometry assays, and mumps immunoglobulin (Ig) G was measured using enzyme-linked immunosorbent assay.
RESULTS: T cell immunity to mumps was high in both groups; 70% of vaccinated and 80% of naturally immune individuals had a positive (> or =3) stimulation index (SI) (P = 1.0). The mean percentages of mumps-specific CD4+ T cells that expressed CD69 and produced IFN-gamma were equivalent in the 2 groups: 0.06% and 0.12%, respectively (P = .11). The mean SIs in the groups were also equivalent, although IFN-gamma concentrations from cultures stimulated with mumps antigen were higher in naturally immune adults than in vaccinated adults (P < or = .01). All adults were positive for mumps IgG.
CONCLUSION: T and B cell immunity to mumps was detected in adults at least 10 years after immunization. Except for IFN-gamma release, responses in vaccinated adults paralleled those observed in naturally immune individuals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18419345      PMCID: PMC2561204          DOI: 10.1086/588195

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  41 in total

1.  Mumps outbreak in a highly vaccinated population.

Authors:  B S Hersh; P E Fine; W K Kent; S L Cochi; L H Kahn; E R Zell; P L Hays; C L Wood
Journal:  J Pediatr       Date:  1991-08       Impact factor: 4.406

2.  Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies.

Authors:  R S van Binnendijk; M C Poelen; G van Amerongen; P de Vries; A D Osterhaus
Journal:  J Infect Dis       Date:  1997-03       Impact factor: 5.226

3.  Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry.

Authors:  M A Suni; L J Picker; V C Maino
Journal:  J Immunol Methods       Date:  1998-03-01       Impact factor: 2.303

4.  Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis.

Authors:  S L Waldrop; K A Davis; V C Maino; L J Picker
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

5.  Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency.

Authors:  S L Waldrop; C J Pitcher; D M Peterson; V C Maino; L J Picker
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

6.  Cell-mediated and humoral immunity to mumps virus antigen.

Authors:  H Hyöty; L Räsänen; M Lehto; P Tanhuanpää; A Eerola; H M Surcel; J Ilonen; P Leinikki
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1986-10

7.  Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity.

Authors:  P A Briss; L J Fehrs; R A Parker; P F Wright; E C Sannella; R H Hutcheson; W Schaffner
Journal:  J Infect Dis       Date:  1994-01       Impact factor: 5.226

8.  Analysis of mumps vaccine failure by means of avidity testing for mumps virus-specific immunoglobulin G.

Authors:  M Narita; Y Matsuzono; Y Takekoshi; S Yamada; O Itakura; M Kubota; H Kikuta; T Togashi
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

9.  Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination.

Authors:  Sari Jokinen; Pamela Osterlund; Ilkka Julkunen; Irja Davidkin
Journal:  J Infect Dis       Date:  2007-08-10       Impact factor: 5.226

10.  Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  J C Watson; S C Hadler; C A Dykewicz; S Reef; L Phillips
Journal:  MMWR Recomm Rep       Date:  1998-05-22
View more
  15 in total

1.  Cytokine production in whole-blood cultures following immunization with an influenza vaccine.

Authors:  Tetsuo Nakayama; Takuji Kumagai; Yasuyo Kashiwagi; Hironori Yoshii; Kenta Honjo; Ritsuko Kubota-Koketsu; Yoshinobu Okuno; Shigeru Suga
Journal:  Hum Vaccin Immunother       Date:  2018-08-28       Impact factor: 3.452

Review 2.  Mumps: an Update on Outbreaks, Vaccine Efficacy, and Genomic Diversity.

Authors:  Eugene Lam; Jennifer B Rosen; Jane R Zucker
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

3.  Detection of mumps virus-specific memory B cells by transfer of peripheral blood mononuclear cells into immune-deficient mice.

Authors:  Corinne Vandermeulen; Lieven Verhoye; Sunil Vaidya; Frédéric Clement; Kevin E Brown; Karel Hoppenbrouwers; Geert Leroux-Roels
Journal:  Immunology       Date:  2010-06-25       Impact factor: 7.397

4.  Mumps virus-specific immune response outcomes and sex-based differences in a cohort of healthy adolescents.

Authors:  Marguerite M Riggenbach; Iana H Haralambieva; Inna G Ovsyannikova; Daniel J Schaid; Gregory A Poland; Richard B Kennedy
Journal:  Clin Immunol       Date:  2021-12-28       Impact factor: 3.969

5.  Novel mumps virus epitopes reveal robust cytotoxic T cell responses after natural infection but not after vaccination.

Authors:  Patricia Kaaijk; Maarten E Emmelot; Hugo D Meiring; Cécile A C M van Els; Jelle de Wit
Journal:  Sci Rep       Date:  2021-07-01       Impact factor: 4.379

6.  Seroprevalence against the measles virus after vaccination or natural infection in an adult population in Madinah, Saudi Arabia.

Authors:  Waleed H Mahallawi; Nadir A Ibrahim
Journal:  Hum Vaccin Immunother       Date:  2021-02-11       Impact factor: 3.452

7.  Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations?

Authors:  J Eriksen; I Davidkin; G Kafatos; N Andrews; C Barbara; D Cohen; A Duks; A Griskevicius; K Johansen; K Bartha; B Kriz; G Mitis; J Mossong; A Nardone; D O'Flanagan; F DE Ory; A Pistol; H Theeten; K Prosenc; M Slacikova; R Pebody
Journal:  Epidemiol Infect       Date:  2012-06-12       Impact factor: 4.434

8.  Short-lived IFN-γ effector responses, but long-lived IL-10 memory responses, to malaria in an area of low malaria endemicity.

Authors:  Jiraprapa Wipasa; Lucy Okell; Supachai Sakkhachornphop; Chaisuree Suphavilai; Kriangkrai Chawansuntati; Witaya Liewsaree; Julius C R Hafalla; Eleanor M Riley
Journal:  PLoS Pathog       Date:  2011-02-10       Impact factor: 6.823

9.  Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles-mumps-rubella-varicella vaccine to children aged 11-21 months.

Authors:  Markus Knuf; Fred Zepp; Claudius U Meyer; Pirmin Habermehl; Lothar Maurer; Hanns-Michael Burow; Ulrich Behre; Michel Janssens; Paul Willems; Helmtrud Bisanz; Volker Vetter; Ruprecht Schmidt-Ott
Journal:  Eur J Pediatr       Date:  2010-02-11       Impact factor: 3.860

10.  Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity.

Authors:  Christina Poethko-Müller; Annette Mankertz
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.